Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chamelli Jhappan is active.

Publication


Featured researches published by Chamelli Jhappan.


Oncogene | 2003

Ultraviolet radiation and cutaneous malignant melanoma

Chamelli Jhappan; Frances P. Noonan; Glenn Merlino

Recent years have seen a steady rise in the incidence of cutaneous malignant melanoma worldwide. Although it is now appreciated that the key to understanding the process by which melanocytes are transformed into malignant melanoma lies in the interplay between genetic factors and the ultraviolet (UV) spectrum of sunlight, the nature of this relation has remained obscure. Recently, prospects for elucidating the molecular mechanisms underlying such gene–environment interactions have brightened considerably through the development of UV-responsive experimental animal models of melanoma. Genetically engineered mice and human skin xenografts constitute novel platforms upon which to build studies designed to elucidate the pathogenesis of UV-induced melanomagenesis. The future refinement of these in vivo models should provide a wealth of information on the cellular and genetic targets of UV, the pathways responsible for the repair of UV-induced DNA damage, and the molecular interactions between melanocytes and other skin cells in response to UV. It is anticipated that exploitation of these model systems will contribute significantly toward the development of effective approaches to the prevention and treatment of melanoma.


Nature Medicine | 2002

Synergism between INK4a / ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis

Richard R. Sharp; Juan A. Recio; Chamelli Jhappan; Toshiyuki Otsuka; Shiquan Liu; Yanlin Yu; Wenjing Liu; Miriam R. Anver; Fariba Navid; Lee J. Helman; Ronald A. DePinho; Glenn Merlino

Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children, yet molecular events associated with the genesis and progression of this potentially fatal disease are largely unknown. For the molecules and pathways that have been implicated, genetic validation has been impeded by lack of a mouse model of RMS. Here we show that simultaneous loss of Ink4a/Arf function and disruption of c-Met signaling in Ink4a/Arf−/− mice transgenic for hepatocyte growth factor/scatter factor (HGF/SF) induces RMS with extremely high penetrance and short latency. In cultured myoblasts, c-Met activation and Ink4a/Arf loss suppress myogenesis in an additive fashion. Our data indicate that human c-MET and INK4a/ARF, situated at the nexus of pathways regulating myogenic growth and differentiation, represent critical targets in RMS pathogenesis. The marked synergism in mice between aberrant c-Met signaling and Ink4a/Arf inactivation, lesions individually implicated in human RMS, suggests a therapeutic combination to combat this devastating childhood cancer.


Journal of Clinical Investigation | 1992

Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach.

Hitoshi Takagi; Chamelli Jhappan; Richard R. Sharp; Glenn Merlino

Transforming growth factor alpha (TGF alpha) is thought to participate in the normal and pathologic processes of numerous tissues, including the gastric mucosa. To explore its role in vivo, transgenic mice were generated overexpressing TGF alpha in the stomach. TGF alpha induced dramatic structural and functional lesions of the glandular stomach that were similar to Ménétriers disease in humans. Transgenic mice developed severe adenomatous hyperplasia that resulted in a striking nodular thickening or hypertrophy of the gastric mucosa. Secretions obtained from affected stomachs contained no detectable gastric acid, suggesting that parietal cell function had been greatly impaired. These findings demonstrate that overproduction of TGF alpha can stimulate cellular proliferation, suppress acid secretion, and perturb organogenesis of the stomach of transgenic mice. Moreover, TGF alpha may contribute to the pathogenesis of related human hypertrophic gastropathies, such as Ménétriers disease.


Molecular and Cellular Biology | 2000

The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase.

Chamelli Jhappan; Timur M. Yusufzai; Stacie Anderson; Miriam R. Anver; Glenn Merlino

ABSTRACT Ionizing radiation (IR) exposure causes mammalian cells to undergo p53-dependent cell cycle arrest and/or apoptosis. The in vivo role of DNA-dependent protein kinase (DNA-PK) in the transduction of the DNA damage signal to p53 remains unresolved. To determine the relationship between DNA-PK and p53, we studied the cell cycle and apoptotic responses to IR in mice deficient in DNA-PK. Using the slipmouse, which harbors an inactivating mutation of the DNA-PK catalytic subunit (DNA-PKcs), we demonstrated not only that these DNA-PKcs null mutants were highly radiosensitive but also that upon IR treatment, p53 accumulated in their cultured cells and tissue. Induced p53 was transcriptionally active and mediated the induction of p21 and Bax inslip cells. Examination of the thymic cell cycle response to IR treatment indicated that the slipG1/S-phase cell cycle checkpoint function was intact. We further show that slip mice exhibited a higher level of spontaneous thymic apoptosis as well as a more robust apoptotic response to IR than wild-type mice. Together, these data demonstrate that the p53-mediated response to DNA damage is intact in cells devoid of DNA-PK activity and suggest that other kinases, such as the product of the gene (ATM) mutated in ataxia telangiectasia, are better candidates for regulating IR-induced phosphorylation and accumulation of p53.


International Journal of Cancer | 2007

TGFβ1 and TGFα contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium

Brian W. Booth; Chamelli Jhappan; Glenn Merlino; Gilbert H. Smith

Growth factors and hormones are responsible for development of the mammary gland and can contribute to mammary carcinogenesis. The transforming growth factors (TGF) α and β1 demonstrate opposing effects on the mammary epithelium. TGFα is a mitogen and survival factor for mammary secretory cells and is often upregulated in cancer, while TGFβ1 may act as a growth suppressor and has been shown to inhibit alveolar development and lactogenesis. To examine the contradistinct effects of TGFα and TGFβ1 on normal mammary epithelium, we crossed MT‐TGFα mice with WAP‐TGFβ1 transgenic mice. The newly generated bitransgenic mice failed to nurse their pups and were resistant to mammary tumorigenesis (0% at 12 months of age), compared to single transgenic MT‐TGFα in which the majority (65% at 12 months of age) of the mice developed hyperplastic alveolar mammary lesions. Transplantation studies showed that bitransgenic tissue was highly resistant to tumor formation even after multiple pregnancies. WAP‐TGFβ1 mammary transplants often failed to grow and fully fill cleared mammary fat pads upon transplantation. This repression of growth was completely reversed in the bitransgenic implants, which grew as well as normal epithelium upon transplantation. In addition, TGF and bitransgenic TGFα/TGFβ1 mice had reduced rates of apoptosis during involution as compared to wild type and TGFβ1. These data demonstrate that TGFβ1 and TGFα exhibit opposing effects upon the proliferation and survival of mammary epithelium when expressed alone but when expressed together result in reciprocally suppressive effects upon one another in the context of mammary development and tumorigenesis.


Genes & Development | 1992

Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

Chamelli Jhappan; Daniel Gallahan; Cheryl Stahle; E Chu; Gilbert H. Smith; Glenn Merlino; Robert Callahan


Cancer Research | 1996

Expression of a Truncated Int3 Gene in Developing Secretory Mammary Epithelium Specifically Retards Lobular Differentiation Resulting in Tumorigenesis

Daniel Gallahan; Chamelli Jhappan; Gertraud W. Robinson; Lothar Hennighausen; Richard R. Sharp; Edith C. Kordon; Robert Callahan; Glenn Merlino; Gilbert H. Smith


Nature Genetics | 1997

DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus

Chamelli Jhappan; Herbert C. Morse; Robert D. Fleischmann; Michael M. Gottesman; Glenn Merlino


Cell Growth & Differentiation | 1995

Constitutive Expression of a Truncated INT3 Gene in Mouse Mammary Epithelium Impairs Differentiation and Functional Development

Gilbert H. Smith; Daniel Gallahan; Francesca Diella; Chamelli Jhappan; Glenn Merlino; Robert Callahan


Cell Growth & Differentiation | 1994

Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.

Chamelli Jhappan; Hisashi Takayama; Robert B. Dickson; Glenn Merlino

Collaboration


Dive into the Chamelli Jhappan's collaboration.

Top Co-Authors

Avatar

Glenn Merlino

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gilbert H. Smith

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Gallahan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Miriam R. Anver

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Robert Callahan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Fariba Navid

St. Jude Children's Research Hospital

View shared research outputs
Top Co-Authors

Avatar

Juan A. Recio

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Lee J. Helman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge